Table 1 Evaluation of the baseline data of studied groups
From: Assessment of serum level of melatonin in migraine: a case control study
| Â | Case group | Control group | Test | p |
|---|---|---|---|---|
N = 70(%) | N = 70(%) | |||
Age; mean ± SD | 34.03 ± 7.42 | 34.06 ± 7.22 | − 0.023¥ | 0.982 |
Sex | ||||
 Male | 24 (34.3%) | 25 (35.7%) | 0.031 | 0.859 |
 Female | 46 (65.7%) | 45 (64.3%) | ||
Education | ||||
 Illiterate | 16 (22.9%) | 7 (10%) | 2.87 | 0.09 |
 Basic | 21 (30%) | 24 (34.3%) | ||
 High | 33 (47.1%) | 39 (55.7%) | ||
Smoking | ||||
 No | 32 (45.7%) | 34 (48.6%) | 0.115 | 0.735 |
 Yes | 36 (54.3%) | 36 (51.4%) | ||
BMI (kg/m2); mean ± SD | 25.58 ± 6.23 | 27.09 ± 5.88 | − 1.471¥ | 0.144 |
Melatonin first sample; mean ± SD | 14.8 ± 3.26 | 21.41 ± 4.1 | − 10.555¥ | < 0.001** |
Melatonin second sample; mean ± SD | 4.94 ± 1.58 | 10.81 ± 3.75 | − 12.075¥ | < 0.001** |
SQS Median(IQR) | 46 (34–60) | 16 (8–24) | − 8.369§ | < 0.001** |
Duration of attack median(IQR) | 8 (6–18) | NA |  |  |
Frequency of attack median(IQR) | 8 (5–11.25) | NA |  |  |
Age of onset median(IQR) | 17 (11–21.25) | NA |  |  |
Severity of attack median(IQR) | 7 (4–13.25) | NA |  |  |